Showing results (261-270 of 390) with videos related to
Sort By:
Pageof 39
Platelets|July 9, 2019
Increased microvesicle-associated thrombin generation in patients with immune thrombocytopenia after initiation of thrombopoietin receptor agonistsLamya Garabet, Waleed Ghanima, Marit Hellum, et al.American Journal of Perinatology|January 1, 1996
Advantages of larger volume, less frequent intrauterine red blood cell transfusions for maternal red cell alloimmunizationS R Inglis, A Lysikiewicz, A L Sonnenblick, et al.Blood|November 22, 2012
Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND studyMansoor N Saleh, James B Bussel, Gregory Cheng, et al.Clinical Therapeutics|August 19, 2007
A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trialSusan D Mathias, James B Bussel, James N George, et al.Clinical and Experimental Immunology|August 22, 2003
T cell receptor VB repertoire diversity in patients with immune thrombocytopenia following splenectomyP F Fogarty, M E Rick, W Zeng, et al.The Cochrane Database of Systematic Reviews|May 13, 2011
Antenatal interventions for fetomaternal alloimmune thrombocytopeniaRachel Rayment, Susan J Brunskill, Peter W Soothill, et al.The Journal of Pediatrics|October 1, 1994
Lactic acidosis and renal enlargement at diagnosis and relapse of acute lymphoblastic leukemiaA A Ali, C D Flombaum, J A Brochstein, et al.Health and Quality of Life Outcomes|February 24, 2007
A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: its development and validationSusan D Mathias, James B Bussel, James N George, et al.British Journal of Haematology|July 29, 2024
Increased risk of haematological malignancy in adults over age 60 with thrombocytopenia compared with matched controls: Time for an upfront bone marrow evaluation?A Vijenthira, A S Wilton, S Lee, et al.Obstetrics and Gynecology|August 2, 2007
Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trialRichard L Berkowitz, Martin L Lesser, Janice G McFarland, et al.Pageof 39